Investor Relations

NASDAQ: CYBX

$ 53.25

0.50 (0.93%)

Day High: 54.18
Day Low:  53.21
Volume:    165,700

1:00 PM ET
Nov 28, 2014


Delayed at least 20 min., by eSignal.

Stock price graph
     

Cyberonics, Inc. (NASDAQ:CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Cyberonics, Inc.'s financial performance into perspective.

View all »   RSSRecent Releases

Nov 24, 2014
Cyberonics To Present At The 26th Annual Piper Jaffray Healthcare Conference

Nov 20, 2014
Cyberonics Reports Fiscal 2015 Second Quarter Results

View all »Events & Presentations

Dec 3, 2014
Piper Jaffray Healthcare Conference

Shareholder Tools                         

Contact Us

100 Cyberonics Boulevard
Houston, Texas USA 77058

Main

800.332.1375

Investor Relations

281.228.7262

Fax

281.218.9332

Transfer Agent Information

Computershare
P.O. BOX 30170
College Station, TX 77842-3170

Overnight correspondence should be sent to:

Computershare
211 Quality Circle, Suite 210
College Station, TX 77845

Shareholder website

www.computershare.com/investor

Shareholder online inquiries

https://www-us.computershare.com/investor/Contact

Proud Member MDMAAdvaMed: Code of ethics supporter

© Cyberonics, Inc. 2014 | All rights reserved.